Initially developed in the 1950s, nitazenes are a type of synthetic opioid that has reappeared in Philadelphia’s street drug supply.
Academic rigour, journalistic flair
Articles on Naloxone
Displaying 1 - 20 of 30 articles
The study discovered that nonmedical personnel can provide the naloxone to an overdose victim in about one minute.
The Food and Drug Administration’s approval of Narcan will make the lifesaving drug more widely available, especially to those who might be likely to witness or respond to opioid overdoses.
Xylazine, or tranq, is increasingly being mixed with drugs like fentanyl or heroin and can be difficult to detect. Most people who use drugs are unable to tell if they have been exposed to it.
Fentanyl’s wide availability in the drug supply has led to an increase in unintentional overdoses. While prevention strategies are available, limited availability stymies their use.
Fentanyl adulteration led to the replacement of heroin in the unregulated drug supply of British Columbia. Now that benzodiazepines are present in many opioids, are we headed towards a ‘new normal?’
Across the country, overdose deaths have spiked during the COVID-19 pandemic.
COVID-19 plagues an overtaxed opioid addiction treatment system.
A new report counts the social costs of pharmaceutical opioid misuse and illegal opioid use in Australia for 2015/2016. The numbers are fairly grim.
Pharmacists are well positioned to provide communities with a lifesaving drug.
Treatments for opioid dependence, such as methadone and buprenorphine, are effective. But some people who stand to benefit are missing out.
Opioid overdoses killed 47,000 Americans in 2017 — more than gun violence. Many fewer would have died if they’d been treated with the life-saving drug naloxone, also called Narcan.
Considered in historical context, Purdue’s plan to peddle opioid addiction medicines to vulnerable people is not so surprising. Gilded-Age pharmaceutical companies used similar strategies.
The toll of the opioid epidemic is often derived from toxicology reports. These rely on drug tests. A medical historian explains these tests and how they fall short of capturing why people are dying.
Naloxone programmes have sprung up in the UK and elsewhere, but drug death rates keep climbing.
There are proven ways to reduce drug deaths. Unfortunately, the UK government is not implementing them.
One study argues that naloxone increases opioid use because it protects against death from overdose. But a closer analysis shows Narcan is the number one public health tool to fight the overdose epidemic.
Opioids kill 100 people each day in the US, more than vehicular accidents. Those addicted are often left without treatment. An addiction researcher offers six steps to address the epidemic.
Catastrophic increases in opioid overdose deaths across Canada require a broad response – tackling housing, food and income insecurity as well as the contaminated drug supply.
Opioids kill an average of eight people every day in Canada. The federal government must officially declare this a ‘public welfare emergency’ and invest the funds critical to a humane response.
Top contributors
-
Professor and Deputy Director, Monash Addiction Research Centre, Monash University
-
Professor of Emergency Medicine, UMass Chan Medical School
-
Professor and Director, National Drug Research Institute, Curtin University
-
Honorary Fellow, Department of Health Sciences, University of York
-
Professor of Intellectual Property, University of California College of the Law, San Francisco
-
University of California, San Francisco
-
Doctoral Candidate, Medical History, Vanderbilt University
-
Professor and Director - Academic Excellence, Macquarie University
-
Professor of Emergency Medicine and Community Health Sciences, Boston University
-
Professor in Criminology, Loughborough University
-
Head of Alcohol and other Drug Research, Centre for Population Health; Burnet Principal for Alcohol, other drugs and harm reduction, Burnet Institute
-
Emeritus Consultant, St Vincent's Hospital, Darlinghurst
-
Senior lecturer, Australian National University
-
Professor of Pharmacology, University of Sydney
-
Postdoctoral Fellow, University of British Columbia
